{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:28:10Z","timestamp":1792718890269,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,29]],"date-time":"2006-07-29T00:00:00Z","timestamp":1154131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2006,11,30]]},"DOI":"10.1007\/s00431-006-0193-1","type":"journal-article","created":{"date-parts":[[2006,7,28]],"date-time":"2006-07-28T07:42:03Z","timestamp":1154072523000},"page":"13-21","source":"Crossref","is-referenced-by-count":38,"title":["Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study"],"prefix":"10.1007","volume":"166","author":[{"given":"Luminita","family":"Ene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Goetghebuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Toppet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,29]]},"reference":[{"key":"193_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","volume":"21","author":"RA Amaya","year":"2002","unstructured":"Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW (2002) Lipodystrophy syndrome in human immunodeficiency virus- infected children. Pediatr Infect Dis J 21:405\u2013410","journal-title":"Pediatr Infect Dis J"},{"key":"193_CR2","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/00002030-199911120-00020","volume":"13","author":"SM Arpadi","year":"1999","unstructured":"Arpadi SM, Cuff PA, Horlick M, Kotler DP (1999) Visceral obesity, hypertriglyceridemia and hypercortisolism in a boy with perinatally acquired HIV infection receiving protease inhibitor- containing antiviral treatment. AIDS 13:2312\u20132313","journal-title":"AIDS"},{"key":"193_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200105010-00005","volume":"27","author":"SM Arpadi","year":"2001","unstructured":"Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP (2001) Lipodystrophy in HIV- infected children is associated with high viral load and low CD4+ - lymphocyte count and CD4+ - lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr 27:30\u201334","journal-title":"J Acquir Immune Defic Syndr"},{"key":"193_CR4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(98)05754-7","volume":"353","author":"FE Babl","year":"1999","unstructured":"Babl FE, Regan AM, Pelton SI (1999) Abnormal body- fat distribution in HIV- 1- infected children on antiretrovirals. Lancet 353:1243\u20131244","journal-title":"Lancet"},{"key":"193_CR5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00126334-200301010-00015","volume":"32","author":"WH Belloso","year":"2003","unstructured":"Belloso WH, Quiros RE, Ivalo SA, Perman MI, Galich AM, Stern LD, Barcan LA (2003) Agreement analysis of variables involved in lipodystrophy syndrome definition in HIV- infected patients. J Acquir Immune Defic Syndr 32:104\u2013111","journal-title":"J Acquir Immune Defic Syndr"},{"key":"193_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.ijo.0802176","volume":"27","author":"M Beregszaszi","year":"2003","unstructured":"Beregszaszi M, Jaquet D, Levine M, Ortega-Rodriguez E, Baltakse V, Polak M, Levy-Marchal C (2003) Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV- infected children with lipohypertrophy. Int J Obes Relat Metab Disord 27:25\u201330","journal-title":"Int J Obes Relat Metab Disord"},{"key":"193_CR7","first-page":"463","volume":"22","author":"JL Bockhorst","year":"2003","unstructured":"Bockhorst JL, Ksseiry I, Toye M, Chipkin SR, Stechenberg BW, Fisher DJ, Allen HF (2003) Evidence of human immunodeficiency virus- associated lipodystrophy syndrome in children treated with protease inhibitors. Pediatr Infect Dis J 22:463\u2013465","journal-title":"Pediatr Infect Dis J"},{"key":"193_CR8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","volume":"348","author":"SA Bozzette","year":"2003","unstructured":"Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702\u2013710","journal-title":"N Engl J Med"},{"key":"193_CR9","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1097\/00002030-200112070-00009","volume":"15","author":"P Brambilla","year":"2001","unstructured":"Brambilla P, Bricalli D, Sala N, Renzetti F, Manzoni P, Vanzulli A, Chiumello G, di Natale B, Vigano A (2001) Highly active antiretroviral- treated HIV- infected children show fat distribution changes even in absence of lipodystrophy. AIDS 15:2415\u20132422","journal-title":"AIDS"},{"key":"193_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/ajcn\/58.6.839","volume":"58","author":"JA Brunton","year":"1993","unstructured":"Brunton JA, Bayley HS, Atkinson SA (1993) Validation and application of dual-energy X-ray absorptiometry to measure bone mass and body composition in small infants. Am J Clin Nutr 58:839\u2013845","journal-title":"Am J Clin Nutr"},{"key":"193_CR11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","volume":"356","author":"A Carr","year":"2000","unstructured":"Carr A, Cooper DA (2000) Adverse effects of antiretroviral therapy. Lancet 356:1423\u20131430","journal-title":"Lancet"},{"key":"193_CR14","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA (1999) Diagnosis, prediction, and natural course of HIV- 1 protease- inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093\u20132099","journal-title":"Lancet"},{"key":"193_CR13","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A, Miller J, Law M, Cooper DA (2000) A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor- related lipodystrophy syndrome. AIDS 14:F25\u2013F32","journal-title":"AIDS"},{"key":"193_CR12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG (2003) An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361:726\u2013735","journal-title":"Lancet"},{"key":"193_CR15","first-page":"1","volume":"43","author":"CDC","year":"1994","unstructured":"CDC (1994) 1994 Revised classification system for human immunodeficiency virus infection in children less than 13\u00a0years of age. MMWR Recomm Rep 43:1\u201310","journal-title":"MMWR Recomm Rep"},{"key":"193_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.104.517144","volume":"112","author":"M Charakida","year":"2005","unstructured":"Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake M, Dunn DT, Halcox JP, Gibb DM, Klein NJ, Deanfield JE (2005) Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 112:103\u2013109","journal-title":"Circulation"},{"key":"193_CR17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00126334-200207010-00004","volume":"30","author":"JJ Cheseaux","year":"2002","unstructured":"Cheseaux JJ, Jotterand V, Aebi C, Gnehm H, Kind C, Nadal D, Rudin C, Lazarevitch CA, Nicod P, Mooser V (2002) Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases. J Acquir Immune Defic Syndr 30:288\u2013293","journal-title":"J Acquir Immune Defic Syndr"},{"key":"193_CR18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","volume":"18","author":"A d\u2019Arminio","year":"2004","unstructured":"d\u2019Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Moller N (2004) Cardio- and cerebrovascular events in HIV-infected persons. AIDS 18:1811\u20131817","journal-title":"AIDS"},{"issue":"3","key":"193_CR19","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.0030052","volume":"3","author":"AS Foulkes","year":"2006","unstructured":"Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP (2006) Associations among race\/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med. 3(3):e52","journal-title":"PLoS Med"},{"key":"193_CR20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"N Friis-Moller","year":"2003","unstructured":"Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El- Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD (2003) Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349:1993\u20132003","journal-title":"N Engl J Med"},{"key":"193_CR21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","volume":"18","author":"Group EPL","year":"2004","unstructured":"Group EPL (2004) Antiretroviral therapy, fat redistribution and hyperlipidemia in HIV-infected children in Europe. AIDS 18:1443\u20131451","journal-title":"AIDS"},{"key":"193_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","volume":"86","author":"C Grunfeld","year":"1989","unstructured":"Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN (1989) Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 86:27\u201331","journal-title":"Am J Med"},{"key":"193_CR23","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","volume":"14","author":"D Jaquet","year":"2000","unstructured":"Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C (2000) Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14:2123\u20132128","journal-title":"AIDS"},{"key":"193_CR24","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","volume":"16","author":"V Joly","year":"2002","unstructured":"Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, Yeni P (2002) Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS 16:2447\u20132454","journal-title":"AIDS"},{"key":"193_CR25","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1542\/peds.110.5.e56","volume":"110","author":"E Lainka","year":"2002","unstructured":"Lainka E, Oezbek S, Falck M, Ndagijimana J, Niehues T (2002) Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor- containing antiretroviral therapy. Pediatrics 110:e56","journal-title":"Pediatrics"},{"key":"193_CR26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","volume":"14","author":"SA Mallal","year":"2000","unstructured":"Mallal SA, John M, Moore CB, James IR, McKinnon EJ (2000) Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14:1309\u20131316","journal-title":"AIDS"},{"key":"193_CR27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","volume":"357","author":"E Martinez","year":"2001","unstructured":"Martinez E, Mocroft A, Garcia-Viejo MA, Perez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Phillips A, Gatell JM (2001) Risk of lipodystrophy in HIV- 1- infected patients treated with protease inhibitors: a prospective cohort study. Lancet 357:592\u2013598","journal-title":"Lancet"},{"key":"193_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-2662.2001.00100.x","volume":"3","author":"S Mauss","year":"2002","unstructured":"Mauss S, M Corzillius, E Wolf, A Schwenk, A Adam, H Jaeger, H Knechten, J Goelz, A Goetzenich (2002) Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3\u00a0years of antiretroviral treatment. HIV Med 3:49\u201355","journal-title":"HIV Med"},{"key":"193_CR29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","volume":"18","author":"GA McComsey","year":"2004","unstructured":"McComsey GA, Leonard E (2004) Metabolic complications of HIV therapy in children. AIDS 18:1753\u20131768","journal-title":"AIDS"},{"key":"193_CR30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","volume":"351","author":"KD Miller","year":"1998","unstructured":"Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871\u2013875","journal-title":"Lancet"},{"key":"193_CR31","unstructured":"Moser W Hugo (2002) Nelson textbook of pediatrics, 17th edn. In: Behrman RE, Jenson HB (ed) Defects in metabolism of lipids. Nelson textbook of pediatrics. Saunders, Elsevier Science, Amsterdam"},{"key":"193_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1071\/SH04058","volume":"2","author":"D Nolan","year":"2005","unstructured":"Nolan D, Mallal S (2005) Antiretroviral therapy-associated lipoatrophy: current status and future directions. Sex Health 2:153\u2013163","journal-title":"Sex Health"},{"key":"193_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3476(98)70175-1","volume":"133","author":"S Owens","year":"1998","unstructured":"Owens S, B Gutin, M Ferguson, J Allison, W Karp, NA Le (1998) Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr 133:41\u201345","journal-title":"J Pediatr"},{"key":"193_CR34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.ijo.0801975","volume":"26","author":"JN Roemmich","year":"2002","unstructured":"Roemmich JN, Clark PA, Lusk M, Friel A, Weltman A, Epstein LH, Rogol AD (2002) Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release. Int J Obes Relat Metab Disord 26:701\u2013709","journal-title":"Int J Obes Relat Metab Disord"},{"key":"193_CR35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, Gastaut JA, Touraine JL (1999) A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long- term nucleoside analogue therapy. AIDS 13:1659\u20131667","journal-title":"AIDS"},{"key":"193_CR36","doi-asserted-by":"crossref","unstructured":"Sanchez Torres AM, R Munoz Muniz, R Madero, C Borque, MJ Garcia- Miguel, MI De Jose Gomez (2005) Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus- infected children. Eur J Pediatr","DOI":"10.1007\/s00431-004-1610-y"},{"issue":"2","key":"193_CR37","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","volume":"114","author":"P Taylor","year":"2004","unstructured":"Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S (2004) Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus- infected children receiving long- term, protease inhibitor- containing, highly active antiretroviral therapy regimens. Pediatrics 114:e235\u2013e242","journal-title":"Pediatrics"},{"key":"193_CR38","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1345\/aph.1A444","volume":"37","author":"ME Temple","year":"2003","unstructured":"Temple ME, Koranyi KI, Nahata MC (2003) Lipodystrophy in HIV- infected pediatric patients receiving protease inhibitors. Ann Pharmacother 37:1214\u20131218","journal-title":"Ann Pharmacother"},{"key":"193_CR39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","volume":"31","author":"R Thiebaut","year":"2000","unstructured":"Thiebaut R, V Daucourt, P Mercie, DK Ekouevi, D Malvy, P Morlat, M Dupon, D Neau, S Farbos, C Marimoutou, F Dabis (2000) Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine. Clin Infect Dis 31:1482\u20131487","journal-title":"Clin Infect Dis"},{"key":"193_CR40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","volume":"15","author":"M Valk van der","year":"2001","unstructured":"van der Valk M, EH Gisolf, P Reiss, FW Wit, A Japour, GJ Weverling, SA Danner (2001) Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection. AIDS 15:847\u2013855","journal-title":"AIDS"},{"key":"193_CR41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","volume":"32","author":"A Vigano","year":"2003","unstructured":"Vigano A, Mora S, Testolin C, Beccio S, Schneider L, Bricalli D, Vanzulli A, Manzoni P, Brambilla P (2003) Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV- infected children. J Acquir Immune Defic Syndr 32:482\u2013489","journal-title":"J Acquir Immune Defic Syndr"},{"key":"193_CR42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1468-1293.2002.00125.x","volume":"3","author":"D Worm","year":"2002","unstructured":"Worm D, Kirk O, Andersen O, Vinten J, Gerstoft J, Katzenstein TL, Nielsen H, Pedersen C (2002) Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance. HIV Med 3:239\u2013246","journal-title":"HIV Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-006-0193-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0193-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:25:49Z","timestamp":1559082349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-006-0193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,29]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,11,30]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1007\/s00431-006-0193-1","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,29]]}}}